Silexion Therapeutics Corp

SLXN NASDAQ Santé & Biotech États-Unis
2.71 $
1.45 %

Silexion Therapeutics Corp se focalise sur le développement de thérapies novatrices contre le cancer.

Performance & Momentum

6 Months 89.46 %
1 Year 97.76 %
3 Years 99.83 %
5 Years 99.81 %

Similar stocks to Silexion Therapeutics Corp

Anantys Community

Be the first to share your analysis on Silexion Therapeutics Corp.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases